Double Viral Vaccine (MR)

measles-rubella vaccine · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Double Viral Vaccine (MR), covering 2020-08-13 to 2020-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella [Phase 2, Phase 3]

See pricing